breast cancer Archive — Page 12 of 23
-
May 30, 2017
Cancer sleuths span the globe tracking down a prolific killer
-
May 30, 2017
Age-Range Screening Recommendations
-
May 30, 2017
Mix-and-match trial is actually precision medicine
-
April 20, 2017
Study examines new breast cancer drug combination
A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy. -
March 30, 2017
Horn to lead lung cancer combination therapy trial
Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has been selected to lead a clinical research trial of combination therapy using two targeted drugs for the treatment of a specific form of lung cancer. -
March 30, 2017
Research support
DS Services of America Inc. recently presented a $100,000 gift to Vanderbilt-Ingram Cancer Center (VICC) to support breast cancer research. -
March 23, 2017
Breast cancer program lands new research grants
Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients.